Empiric Antibiotics for Meningitis
For adults with suspected bacterial meningitis, immediately initiate IV ceftriaxone 2g every 12 hours (or cefotaxime 2g every 6 hours) PLUS dexamethasone 10mg every 6 hours for 4 days, with the dexamethasone given 15-20 minutes before or with the first antibiotic dose. 1
Age-Based Antibiotic Regimens
Adults Under 60 Years
- Primary regimen: Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours 1
- Alternative (if beta-lactam allergy): Chloramphenicol 25 mg/kg IV every 6 hours 1
Adults 60 Years or Older
- Primary regimen: Ceftriaxone 2g IV every 12 hours OR Cefotaxime 2g IV every 6 hours 1
- PLUS Amoxicillin 2g IV every 4 hours (for Listeria coverage) 1
- Alternative: Chloramphenicol 25 mg/kg IV every 6 hours PLUS Co-trimoxazole 10-20 mg/kg (of trimethoprim component) in 4 divided doses 1
Special Circumstances Requiring Additional Coverage
Add vancomycin 15-20 mg/kg IV every 12 hours OR rifampicin 600 mg IV/PO every 12 hours if: 1
- Recent travel (within 6 months) to areas with high penicillin-resistant pneumococcal rates
- Known local resistance patterns suggest resistant pneumococci
Adjunctive Dexamethasone Protocol
Dexamethasone is strongly recommended and significantly reduces mortality, hearing loss, and neurological sequelae in bacterial meningitis. 2
Dosing
Critical Timing
- Optimal: Give 15-20 minutes before first antibiotic dose 3
- Acceptable: Give with first antibiotic dose 2
- Latest acceptable: Up to 4 hours after first antibiotic dose 2
The evidence strongly supports that dexamethasone reduces unfavorable outcomes from 25% to 15% and mortality by approximately 50% in adults with bacterial meningitis 3. The benefit is most pronounced in pneumococcal meningitis, where unfavorable outcomes decreased from 52% to 26% 3.
When to Stop Dexamethasone
Discontinue dexamethasone if: 2
- Patient does not have bacterial meningitis
- Causative organism is identified as species other than S. pneumoniae or H. influenzae (though some experts continue regardless of organism)
Note: For meningococcal meningitis, subgroup analyses showed no significant benefit, but this may reflect lower baseline event rates rather than true lack of efficacy 2.
Pathogen-Specific Definitive Therapy
Pneumococcal Meningitis
- Penicillin-sensitive (MIC ≤0.06): Benzylpenicillin 2.4g IV every 4 hours OR continue ceftriaxone/cefotaxime 1
- Penicillin-resistant, cephalosporin-sensitive: Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
- Dual resistance: Ceftriaxone/cefotaxime PLUS vancomycin 15-20 mg/kg IV every 12 hours PLUS rifampicin 600 mg IV/PO every 12 hours 1
- Duration: 10 days if stable by day 10; extend to 14 days if slow response or resistant organism 1
Meningococcal Meningitis
- Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
- Alternative: Benzylpenicillin 2.4g IV every 4 hours 1
- Duration: 5 days if recovered 1
- Add: Single dose ciprofloxacin 500 mg PO if not treated with ceftriaxone (for eradication) 1
Listeria Meningitis
- Amoxicillin 2g IV every 4 hours 1
- Alternative: Co-trimoxazole 10-20 mg/kg (trimethoprim component) in 4 divided doses 1
- Duration: 21 days 1
H. influenzae Meningitis
- Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
- Alternative: Moxifloxacin 400 mg IV daily 1
- Duration: 10 days 1
Critical Clinical Pearls
Vancomycin penetration concerns: Despite theoretical concerns about dexamethasone reducing vancomycin CSF penetration, adequate CSF levels are achieved with proper dosing (60 mg/kg/day continuous infusion after 15 mg/kg loading dose) 4. The CSF-to-serum ratio correlates positively with CSF protein levels 4.
Timing is everything: The single most important modifiable factor for outcome is rapid antibiotic initiation 5, 6. If lumbar puncture is delayed for any reason (e.g., need for CT imaging due to focal signs, seizures, or severely impaired consciousness), start antibiotics and dexamethasone immediately after blood cultures 6.
Dexamethasone safety: The landmark European study showed no increase in gastrointestinal bleeding with dexamethasone (2 patients vs 5 in placebo group) 3. However, this benefit applies primarily to high-income countries with advanced medical care; studies in low-income countries have not shown benefit 2.
Neonatal exception: Dexamethasone is NOT recommended for neonatal meningitis per the ESCMID guideline 2, though one small trial showed mortality benefit 7. This remains controversial.